EUVIMEDEUVIMED entdecken
Übersichtsarbeit

O-GlcNAcylation and Its Roles in Neurodegenerative Diseases

Pengyang Du, Xiaomin Zhang, Xia Lian, Christian Hölscher, Guofang Xue

Journal of Alzheimer's Disease · 2024

DOI: 10.3233/jad-230955 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Alzheimer's Disease, 2024. Verfasst von Pengyang Du und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Second Hospital of Shanxi Medical University, Taiyuan, China. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Alzheimer Disease. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 133 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As a non-classical post-translational modification, O-linked β-N-acetylglucosamine (O-GlcNAc) modification (O-GlcNAcylation) is widely found in human organ systems, particularly in our brains, and is indispensable for healthy cell biology. With the increasing age of the global population, the incidence of neurodegenerative diseases is increasing, too. The common characteristic of these disorders is the aggregation of abnormal proteins in the brain. Current research has found that O-GlcNAcylation dysregulation is involved in misfolding or aggregation of these abnormal proteins to mediate disease progression, but the specific mechanism has not been defined. This paper reviews recent studies on O-GlcNAcylation’s roles in several neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, Huntington’s disease, Machado-Joseph’s disease, and giant axonal neuropathy, and shows that O-GlcNAcylation, as glucose metabolism sensor, mediating synaptic function, participating in oxidative stress response and signaling pathway conduction, directly or indirectly regulates characteristic pathological protein toxicity and affects disease progression. The existing results suggest that targeting O-GlcNAcylation will provide new ideas for clinical diagnosis, prevention, and treatment of neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesAlzheimer DiseaseHumansProtein Processing, Post-TranslationalProteinsAcetylglucosamineDisease ProgressionN-Acetylglucosaminyltransferases

Stichwörter der Autor:innen

Alzheimer’s diseaseO-GlcNAc transferaseO-GlcNAcase inhibitorsO-GlcNAcylationParkinson’s diseaseneurodegenerative diseases

Substanzen

ProteinsAcetylglucosamineN-Acetylglucosaminyltransferases

Autor:innen und Institutionen

  • Department of Neurology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
  • Academy of Chinese Medical Science, Henan University of Chinese Medicine, Zhengzhou, China.

Zitieren

APA

Du, P., Zhang, X., Lian, X., Hölscher, C., & Xue, G. (2024). O-GlcNAcylation and Its Roles in Neurodegenerative Diseases. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-230955

Vancouver

Du P, Zhang X, Lian X, Hölscher C, Xue G. O-GlcNAcylation and Its Roles in Neurodegenerative Diseases. Journal of Alzheimer's Disease. 2024. doi:10.3233/jad-230955

BibTeX
@article{Du2024,
  author = {Du, Pengyang and Zhang, Xiaomin and Lian, Xia and Hölscher, Christian and Xue, Guofang},
  title = {O-GlcNAcylation and Its Roles in Neurodegenerative Diseases},
  journal = {Journal of Alzheimer's Disease},
  year = {2024},
  doi = {10.3233/jad-230955}
}
Kostenlos starten →